Laparoscopic second look operation for ovarian cancer: Single center experiences

Minimally Invasive Therapy and Allied Technologies

Volumn 20, Issue 6, 2011, Pages 346-351

  Hong, Dae Gy ^a   Park, Nae Yoon ^a   Chong, Gun Oh ^a   Cho, Young Lae ^a   Park, Il Soo ^a   Lee, Yoon Soon ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

Laparoscopy; Ovary carcinoma; Second look operation

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; LAPAROSCOPY; LAPAROTOMY; OVARY CANCER; PRIORITY JOURNAL;

ADULT; AGED; FEMALE; HUMANS; LAPAROSCOPY; LAPAROTOMY; MIDDLE AGED; OVARIAN NEOPLASMS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SECOND-LOOK SURGERY; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 81355147225     PISSN: 13645706     EISSN: 13652931     Source Type: Journal    
DOI: 10.3109/13645706.2011.556648     Document Type: Article

References (27)

1. LeBlanc E, Querleu D, Narducci F, Occelli B, Papageorgiou T, Sonoda Y. Laparoscopic restaging of early stage invasive adnexal tumors; a 10-year experience. Gynecol Oncol. 2004;94:624-9. (Pubitemid 39194452)
2. Chi DS, Abu-Rustum NR, Sonoda Y, Awtrey C, Hummer A, Venkatraman ES, et al. Ten-year experience with laparoscopy on a gynecologic oncology service: Analysis of risk factors for complications and conversion to laparotomy. Am J Obstet Gynecol. 2004;191:1138-45. (Pubitemid 39421563)
3. Querleu D, Papageorgiou TH, Lambaudie E, Sonoda Y, Narducci F, LeBlanc E. Laparoscopic restaging of borderline ovarian tumors: results of 30 cases initially presumed as stage IA borderline ovarian tumors. BJOG 2003;110:201-4. (Pubitemid 36263117)
4. Ovarian Cancer. Screening, treatment, and follow-up. NIH consensus conference. JAMA 1995:491-7.
5. Copeland LJ, Gershenson DM, Wharton JT, Atkinson EN, Sneiqe N, Edwards CL, et al. Microscopic disease at secondlook laparotomy in advanced ovarian cancer. Cancer 1985;55: 472-8. (Pubitemid 15152826)
6. Gershenson DM, Copeland LJ, Wharton JT, Atkinson EN, Sneiqe N, Edwards CL, et al. Prognosis of surgically determined complete responders in advanced ovarian cancer. Cancer 1985;55:1129-35. (Pubitemid 15128677)
7. Luesley D, Lawton F, Blackledge G.. Failure of second look laparotomy to influence survival in epithelial ovarian cancer. Lancet 1988;2:599-603.
8. Freidman JB, Weiss NS. Second thoughts about second-look laparotomy in advanced ovarian cancer. N Eng J Med. 1990; 322:1079-82. (Pubitemid 20146670)
9. Berek JS. Second-look versus second-nature. Gyecol Oncol. 1992;44:1-2.
10. Prayer L, Kainz C, Kramer J, Stiqlbauer R, Schurawitzki H, Baldt M, et al. CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer. J comput-Assist Tomogr. 1993;17:626-32. (Pubitemid 23206748)
11. Forstner R, Hricak H, Ccchipinti KA, Powekk CB, Frankel SD, Stern JL. Ovarian cancer: staging with CT and MR imaging. Radiology 1995;197:619-26.
12. Kurtz AB. Tsimikas JV, Tempany CM, Hamper UM, Arger PG, Bree RL. Diganosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis-report of the Radiology Diagnostic Oncology Group. Radiology 1999;212:19-27. (Pubitemid 29302506)
13. Tempany CM, Zou KH, Silverman SG, Brown DL, Kurtz AB, McNeil BJ. Staging of advanced ovarian cancer: comparison of imaging modalities- report from the Radiological Diagnostic Oncology Group. Radiology 2000;215: 761-7. (Pubitemid 30346013)
14. Low RN, Semelka RC, Worawattanakul S, Alzate GD, Sigeti JS. Extrahepatic abdominal imaging in aging and helical CT, with subsequent surgical correlation. Radiology 1999; 210:625-32.
15. Low RN, Saleh F, Song SY, Shiftan TA, Barone RM, Lacey CG, et al. Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination - a longitudinal study. Radiology 1999;211: 519-28. (Pubitemid 29206825)
16. Zimny M, Siggelkow W, Schroder W, Nowak B, Biemann S, Rath W, et al. 2-[fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol. 2001;83:391-2.
17. Kubik-Huch RA, Dorffler W, von Schulthess GK, Marince B, Kochli OR, Seifert B, et al. Value of (18F)-FDG positron emission tomography,computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma. Eur Radiol. 2000;10: 761-7. (Pubitemid 30321087)
18. Karlan BY, Hawkins R, Hoh C, Lee M, Tse N, Cane P, et al. Whole-body positron emission tomography with 2-[18F]- fluoro-2-deoxy-d-glucose can detect recurrent ovarian carcinoma. Gynecol Oncol. 1993;51:175-81.
19. Cho SM, Ha HK, Byun JY, Lee JM, Kim CJ, Nam Koong SE, et al. Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer. AJR Am J Roentgenol. 2002;179:391-5. (Pubitemid 34785642)
20. Abu-Rustum NR, Barakat RR, Siegel PL, Venkatraman E, Curtin JP, Hoskins WJ. Second-look operation for epithelial ovarian cancer: laparoscopy or laparotomy? Obstet Gynecol. 1996;884:549-53. (Pubitemid 26326016)
21. Husain A, Chi DS, Prasad M, Abu-Rustumz N, Barakat RR, Brown CL, et al. The role of laparoscopy in second-look evaluations for ovarian cancer. Gynecol Oncol. 2001;80: 44-7. (Pubitemid 32062087)
22. Clough K, Ladonne JM, Nos C, Renolleau C, Validire P, Durand JC. Second look for ovarian cancer: laparoscopy or laparotomy? A prospective comparative study. Gynecol Oncol. 1999;72:411-17. (Pubitemid 29118201)
23. Berek JS, Griffith CT, Leventhal JM. Laparoscopy for second- look evaluation in ovarian cancer. Obstet Gynecol. 1981; 58:192-8. (Pubitemid 11093356)
24. Lele S, Piver MS. Interval laparoscopy prior to second-look laparotomy in ovarian cancer. Obstet Gynecol. 1986;68: 345-9.
25. Russo A, Cirelli G, Cassese E, Delli Ponti D, Sgambata R, Cecere F, et al. Second-look in ovarian cancer: laparoscopy or laparotomy? Minerva Ginecol. 2001;53: 146-54. (Pubitemid 33632073)
26. Husain A, Chi DS, Prasad M, Abu-Rustum N, Barakat RR, Brown CL, et al. The role of laparoscopy in second-look evaluations for ovarian cancer. Gynecol Oncol. 2001;80: 44-7. (Pubitemid 32062087)
27. Littell RD, Hallonquist H, Matulonis U, Seiden MV, Berkowitz RS, Duska LR. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma. Gynecol Oncol. 2006;103:570-4. (Pubitemid 44602169)